Clinical Trial Update: A Comparative Study Between Foraseq and Formoterol/Budesonide Inhalation Capsules in Patients with Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Foraseq with Formoterol/Budesonide inhalation capsules in asthma has completed. The study reports results from this pivotal comparison.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Foraseq
• Formoterol/Budesonide Inhalation Capsules (budesonide/formoterol)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: ASTHMA | Phase 3 | Status: COMPLETED